As part of its long-term strategy to expand its footprint in the dental technology market, LED Medical Diagnostics, Inc. ($LMD:CA), announced that has completed the second tranche of debenture financing, essentially securing capital in order to get back to what they do best: pioneering dental imaging technology.
Debenture is an unsecured debt instrument, backed only by the good reputation of the issuer. Disclosed by LED Medical on July 22, 2015, the company issued $500,000 of 10-percent senior secured debentures each in the amount of $10,000 (U.S.) and maturing after 12 months during this second tranche. Bloom Burton Healthcare Lending Trust, a company that provides a number of financial services to companies within the healthcare industry, is the lender of all debentures.
With funding from Bloom Burton, LED Medical can finance general corporate purposes and focus on developing technology that aids in the early diagnosis of oral cancer. In April, the company launched the cloud-based imaging solution, the LED Imaging Cloud. Dentists and practitioners have real-time, remote access to clinical data for their entire patient database 24 hours a day, seven days a week. Recently, LED Medical approached Bloom Burton to act as financial advisor during the LED Medical’s acquisition of a profitable technology company. By expanding their intellectual properties, LED Medical can stay on top of the latest technology in development in order to provide dentists and oral practitioners life-saving tools.
"We are on a rapid revenue growth trajectory and plan to continue growing organically, but we are also interested in a strategic acquisition or two,” said David Gane, CEO of LED Medical. “The management team has experience in M&A in this space, which is an asset we’ll leverage opportunistically. Also, we plan to make additional product release announcements in the near future."
Based in Burnaby, British Columbia, LED Medical provides dentists and oral practitioners with advanced diagnostic imaging products through its subsidiaries, LED Dental Inc. and LED Dental Ltd. Used to detect oral cancer and bacterial infections, the company’s FDA approved VELscope® Vx Enhanced Oral Assessment System is currently used by 12,000 dental practitioners in 23 countries.
The financing enables LED Medical to continue their crucial and innovative work in developing advanced dental imaging solutions.
In June, Equities.com had the opportunity to speak with David Gane of LED Medical to learn more about the company’s current and future product offerings. You can read the interview here. For more information about LED Medical, visit www.leddental.com.
Disclosure: In the purview of Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention the fact that Equities.com, Inc. may be compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker, broker dealer, investment advisor, analyst, investment banker or underwriter. All profiles are based on information that is available to the public. The information contained herein should not be considered to be all-inclusive and is not guaranteed by Equities.com to be free from misstatement or errors. Readers are reminded to do their own due diligence when researching any companies mentioned on this website.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer